Search This Blog

Tuesday, September 18, 2018

Surface Oncology initiated at Baird


Surface Oncology initiated with an Outperform at Baird. Baird analyst Michael Ulz initiated Surface Oncology with an Outperform and $23 price target.
https://thefly.com/landingPageNews.php?id=2792255
Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)